Electronic care records — Can they fulfil their promise?  by Wainwright, Claire E. & Tullis, Elizabeth
Editorialwww.elsevier.com/locate/jcf
Journal of Cystic Fibrosis 13 (2014) 608–609Electronic care records — Can they fulﬁl their promise?There is a growing use of electronic health care records with
adoption rates reported recently of 69% in the United States and
57% in Canada [1]. Unfortunately the huge promise of electronic
care records (ECRs) to improve access to information including
information on costs, along with improved care coordination and
planning, and improved access to alerts and decision tools to
enhance patient safety, along with an ability to easily audit and
benchmark health care outcomes and enhance clinical research,
has to date not been generally realised [2,3]. There have been
many research papers published examining the perceived barriers
to update of the ECR as perceived by physicians and a systematic
review identified 8 main categories of barriers [4,5]. An
appreciation of these barriers is helpful to ensuring better success
in ECR uptake.
Financial barriers are frequently cited as a major issue and
include start-up costs (hardware, software, installation costs) as
well as ongoing costs for maintaining and supporting the system.
Technical problems are a concern to physicians and range from
poor typing and data entry skills on the part of the physicians to the
challenges of linking the ECR with the other electronic systems
(e.g. institutional pathology systems) in use in the medical setting
to allow data exchange. The impact of ECR on a workflow is a
recognised problem. In addition to the time needed to learn the
system, physicians express concern about the time taken to enter
data with each patient encounter. The patient encounter may also
be altered by ECR as eye contact with patients may be replaced
with increased screen gaze time. In some USA centres, physician
assistants are being used to enter data and type up themedical note
so that the physicians can focus entirely on the patient. Wide
adoption of ECR requires participation of all members of the
physician and health care team. Leadership is important to drive
the process of change and support the team during the early,
often-painful implementation stage.
In this edition of the Journal of Cystic Fibrosis, Peckham et al.
report their experience of establishing a disease specific electronic
health record for cystic fibrosis (CF) across three hospital sites
which included two CF Specialist centres one adult and one
paediatric that challenges the pessimistic view of eHealth to date
[6]. The ECR was implemented over 12 months and has used
an internationally recognised extensive system of medical
terms (SNOMED clinical terms), which enhances standardisation,
facilitates data entry and improves data quality as well ashttp://dx.doi.org/10.1016/j.jcf.2014.04.009
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boundaries. In addition, the development and expansion of specific
coding for CF enables this ECR to provide CF specific data and
audit. The specificity for CF overcomes a common barrier of the
lack of customizability seen in many general electronic medical
records.
In contrast to most ECR systems, this disease specific
ECR appears to have been widely accepted by the staff. The
development of the system in close collaboration with all the
members of the health care team may well have contributed to
this success in the three hospitals. In addition, the leadership
and vision of the developer, as well as the support of the other
CF physicians, facilitated the successful adoption of this
ECR. Whether this will translate to usability in other CF
centres will be of enormous interest.
The costs of implementing the system seem remarkably low.
However, the costs were reduced substantially by the involvement
of the project team and lead clinician in the process and of the
upgrades that were happening in parallel in the National Health
System. It will be helpful to know the extent of ongoing costs
related to maintenance and upgrades to the system. Health
managers will be particularly interested to see the benefits of this
system in attributing costs appropriately along with the potential
savings in long-term salaries for secretarial staff.
The details of how this ECR integrates with other hospital
systems such as radiology and laboratory services would
determine if this ECR could be as easily implemented into
other CF clinics outside of the National Health System. One
of the difficulties in establishing a disease-specific record is the
integrationwith existing general electronic records in an institution
and the ability of health care professionals outside the CF team,
such as surgeons, endocrinologists and others, to add clinical
notes. Peckham et al. have resorted to using paper records that are
scanned into the ECR to manage this situation. It is perhaps time
that the large companies that produce ECRs for general use
consider the benefit of disease-specific ECRs to support specialist
requirements. They could facilitate easy integration with emerging
disease-specific ECRs to improve communication and uptake of
ECRs across future and existing systems.
Most countries have CF Patient Registries that collect data on
patient encounters and outcomes (pulmonary function, microbiol-
ogy, exacerbation rate) and provide information that is helpful topean Cystic Fibrosis Society. All rights reserved.
609Editorialtrack the overall health of the CF population. These Data Registries
are not nimble enough to provide support for day-to-day decisions
in part because the data entry is not always in real time. However,
it would be very helpful for the ECR to link with the Registry to
avoid the need for repeated data entry, a convenience that would
reduce errors and save time. It is encouraging to see that this
ECR has the potential to be integrated with the UK National CF
Registry, although somewhat surprising given the potential to
reduce data entry burden that this has not already been done.
The establishment of the disease-specific ECR has led to
substantial improvement in meeting standards for performing
specific screening tests. A large number of alerts and drug
reactions were also tracked highlighting the benefits of such a
system. Communication with primary health care also improved
dramatically despite the increase in patient numbers and workload.
It is likely that these improvements will be translated into better
health outcomes for patients in the future.
When compared with other diseases, the details of CF care
(i.e. standards of care with respect to frequency of follow-up,
screening for disease complications, nutritional guidelines and
use of chronic pulmonary medications) are remarkably similar
between Western countries. This standardisation may allow for
more likely establishment of a common ECR into CF clinics
around the world.
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